THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

Federal contract awards won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER (UEI S3GMKS8ELA16), 2010–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

34
awards
8
expiring in 12 months
2
agencies

Teaming snapshot

teams under 3 primes.

From subcontract reports primes file with USAspending/FSRS.

How their work has changed

Their work has changed a lot over the last two years.

Biggest change: Research and Development in Biotechnology (except Nanobiotechnology) (541714) went from 13% of their contracts to 45%.

Industry (NAICS)2 years beforeLast 2 years
Research and Development in Biotechnology (except Nanobiotechnology) (541714)13%45%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) (541712)25%5%
Research and Development in the Social Sciences and Humanities (541720)13%0%
Veterinary Services (541940)0%9%
All Other Animal Production (112990)19%27%

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 19, 2026. Shown only for companies with at least 5 contracts in each period.

Where their reported work happens

StateReported subawards
TX1

Place of performance on subcontract reports filed with USAspending/FSRS.

Category award history

40 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO took Department of Health and Human Services 541714 work from THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER (Oct 25, 2026).

Agencies buying from THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

Awards

OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
Department of Health and Human Services · $1,578,579 · Sep 1, 2026
BORDETELLA-FREE BABOONS FOR PERTUSSIS INFECTION AND VACCINATION STUDIES
Department of Health and Human Services · $368,627 · Aug 31, 2026
BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6
Department of Health and Human Services · $1,184,156 · Sep 16, 2025
MED PHYSICS PEER REVIEW SERVICES
Department of Veterans Affairs · $1,147,040 · Sep 30, 2024
TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION
Department of Health and Human Services · $551,730 · Sep 20, 2024
TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER
Department of Health and Human Services · $1,272,481 · Sep 15, 2023
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
Department of Health and Human Services · $1,293,012 · Jul 26, 2023
TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA
Department of Health and Human Services · $1,249,115 · Jun 26, 2023
RHESUS, INDIAN ORIGIN, EVEN GENDER, - 2 YRS OF AGE, SPF IAW RFQ NC42. (75N98021D00018)
Department of Health and Human Services · $255,965 · Jul 16, 2022
MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS
Department of Veterans Affairs · $662,700 · Sep 30, 2021
TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE
Department of Health and Human Services · $930,247 · Sep 16, 2021
OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
Department of Health and Human Services · $8,683,558 · Dec 1, 2020
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
Department of Health and Human Services · $1,191,330 · Sep 21, 2020
NATIONAL CORD BLOOD INVENTORY
Department of Health and Human Services · $67,006,495 · Sep 27, 2019
CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS
Department of Health and Human Services · $1,227,167 · Sep 15, 2019
REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER
Department of Health and Human Services · $912,585 · Sep 15, 2019